First, the expression of TOP2B in neuroblastoma cell lines was well maintained in patient primary tumors (median expression 104.74 TPM in DepMap neuroblastoma cell lines and 132.4 TPM in our patient tumor cohort; Fig. 5C left). This evidence concerns the gene TOP2B and neuroblastoma.